Pfizer Gains Novel Anti-Infective In Deal With Elusys
This article was originally published in The Pink Sheet Daily
Executive Summary
The HP antibody ETI-211 is scheduled to enter the clinic in 2008.
You may also be interested in...
Pfizer Receives “Approvable” Letter For MRSA Antibiotic Dalbavancin
Broad range of issues - from trial design to manufacturing - must be addressed before firm can add product to its antibiotic portfolio.
Pfizer Receives “Approvable” Letter For MRSA Antibiotic Dalbavancin
Broad range of issues - from trial design to manufacturing - must be addressed before firm can add product to its antibiotic portfolio.
Pfizer To Spring Forward With Eraxis Launch
Anidulafungin is approved for treatment of esophageal candidiasis and candidemia.